BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2003
View Archived Issues
Shire BioChem scientists report new agents for hepatitis C virus
Read More
Novel antifungal macrolides isolated and tested by Ajinomoto scientists
Read More
Calcium antagonists and their use in IBS reported by Ajinomoto
Read More
Ono identifies novel cysteine protease inhibitors
Read More
Boehringer Ingelheim claims new cathepsin inhibitors for osteoporosis, arthritis, etc.
Read More
HMG-CoA-inhibitory simvastatin analogues covered by Ranbaxy patent
Read More
New CRF1 receptor modulators and their use in anxiety, depression and bowel disorders
Read More
Allosteric AMPA modulators discovered by Boehringer Ingelheim researchers
Read More
Phase II Liprostin study cleared to begin
Read More
GTx and Wyeth enter agreement for VSV-based therapeutics and vaccines
Read More
Genome Therapeutics and MerLion form antiinfective drug discovery collaboration
Read More
Solvay and Innogenetics extend research collaboration
Read More
Epicyte advances production of human HIV antibodies in plants
Read More
NicOx and Biolipox expand research on NO-donating respiratory drugs
Read More
Tarceva phase III trial in pancreatic cancer achieves target enrollment
Read More
AlphaRx acquires exclusive rights to VT-1
Read More
Alliance and Baxter to restructure Oxygent agreement
Read More
High-affinity sigma receptor ligand SSR-125392A effective in animal models of GVHD and RA
Read More
Ref-1/AP-1 validated as therapeutic target for asthma in recent PNAS article
Read More
FDA issues complete response letter for Aldurazyme
Read More
U.S. phase II trial of antibody targeting IL-15 cleared
Read More
First clinical study of IPL-512602 under way in the U.S.
Read More
Second filing announced for YM-905
Read More
Amylin acquires rights to GLP-1 program from Restoragen
Read More
Triangle now part of Gilead
Read More
